The first CRISPR gene-editing medicine just got approved in the US! Here’s what’s happening: The new therapy called Casgevy treats sickle cell disease, where a mutated version of a protein called hemoglobin turns healthy red blood cells into harder “crescent” cells which can clump together and can c
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.